Statistik Austria. Webpräsenz. 2020. www.statistik-austria.at. Zugriffen: 20.4.2020
WHO. Elderly population. 2020. http://origin.searo.who.int/entity/health_situation_trends/data/chi/elderly-population/en/. Zugriffen: 20.4.2020
Hawkes K, Coxwoth JE. Grandmothers and the evolution of human longevity: a review of findings and future directions. Evol Anthropol. 2013;22(6):294–302.
Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151:U25–U37.
Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev. 1995;16(6):686–715.
Veldhuis JD. Changes in pituitary function with aging and implications for patient care. Nat Rev Endocrinol. 2013;9(4):205–15.
Bowers J, Terrein J, Clerget-Froidevaux MS, et al. Thyroid hormone signaling and homeostasis during aging. Endocr Rev. 2013;34(4):556–89.
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.
Ravaglia G, Forti P, Maioli F. Blood micronutrient and thyroid hormone concentrations in the oldest-old. J Clin Endocrinol Metab. 2000;85:2260–5.
Atzmon G, Barzilai N, Hollowell JG, et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab. 2009;94(4):1251–4.
Atzmon G, Barzilai N, Surks MI, Gabriely I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009;94(12):4768–75.
Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Frölich M, de Craen AJ, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010;95:4979–84.
Jansen SW, Roelfsema F, van der Spoel E. Familial longevity is associated with higher TSH secretion and strong TSH-fT3 relationship. J Clin Endocrinol Metab. 2015;100(10):3806–13.
Ogliari G, Smit RA, van der Spoel E, et al. Thyroid status and mortality risk in older adults with normal thyrotropin: sex differences in the Milan geriatrics 75+ cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(4):554–9.
Bremner AP, Feddema P, Leedmann PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554–62.
Waring AC, Arnold AM, Newman AB, et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944–50.
van de Ven AC, Netea-Maier RT, Smit JW, et al. Thyrotropin versus age relation as and indicator of historical iodine intake. Thyroid. 2015;25:629–34.
Pearce SH, Razvi S, Yadegarfar ME, et al. Serum thyroid function, mortality and disability in advanced old age: the newcastle 85+ study. J Clin Endocrinol Metab. 2016;101(11):4385–94.
Vadiveloo T, Donnan PT, Murphy MJ, et al. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). J Clin Endocrinol Metab. 2013;98(3):1147–53.
Gourmelon R, Donadio-Andréi S, Chikh K, et al. Subclinical hypothyroidism: Is it really subclinical with aging? Aging Dis. 2019;10(3):520–9.
Garber JR, Cobin RH, Gharib H, Hennessey JV, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.
Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA guidelines: the use of L‑T4 + L‑T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71.
Gupta G, Sharma P, Kumar P, Itagappa M. Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res. 2015;9(11):BC4–BC6.
Yang C, Lu M, Chen W, et al. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques. J Exp Med. 2019;216(5):1182.
Bano A, Chaker L, de Maat MPM, et al. Thyroid function and cardiovascular disease: the mediating role of coagulation factirs. J Clin Endocrinol Metab. 2019;104:3203–12.
Cai Y, Manio MM, Leung GP, et al. Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries. Eur J Pharmacol. 2015;747:18–28.
Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, boderline hypothyroidism, and high-normal serum (TSH) values. Thyroid. 1997;7:411–4.
Beukhof CM, Massolt ET, Visser TJ, et al. Effects of thyrotropin on peripheral thyroid hormone metabolism and serum lipids. Thyroid. 2018;28(2):168–74.
Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L‑thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–23.
Andersen MN, Olsen AM, Madsen JC, et al. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One. 2015;10(6):e129793.
Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132(4):270–8.
Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 2019;366:I4892.
He W, Li S, Zhang JA, et al. Effect of levothyroxine on blood pressure in patients with subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol. 2018;9:454.
Meier C, Staub JJ, Roth CB, et al. TSH-controlled L‑thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860–6.
Calsolaro V, Niccolai F, Pasqualetti N. Overt and subclinical hypothyroidism in the elderly: when to treat? Front Endocrinol (Lausanne). 2019;10:177.
Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591–9.
Pasqualetti G, Pagano G, Rengo G. Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(11):4240–8.
Virgini VS, Rodondi N, Cawthon PM. Subclinical thyroid dysfunction and frailty among older men. J Clin Endocrinol Metab. 2015;100(12):4524–32.
Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376:2534–44.
Roberts L, McCahon D, Johnson O. Stability of thyroid function in older adults: the Birmingham Elderly Thyroid study. Br J Gen Pract. 2018;68(675):e718–e26.
Pearce SHS, Brabant G, Duntas LH, et al. ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28.
Bensenor IM, Olmos RD, Lotufo PA. Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging. 2012;7:97–111.
Vanderpump MP, Tunbridge WM, French JM. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68.
Knudsen N, Bülow I, Jørgensen T, et al. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143:485–91.
Laurberg P, Pedersen KM, Hreidarsson A, et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998;83(3):765–9.
Ross DS, Burch HB, Cooper DS. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421.
Trivalle C, Doucet J, Chassagne P. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;44(1):50–3.
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.
Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895.
Baumgartner C, da Costa BR, Collet TH. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100–16.
Heidari R, Niknahad H, Jamshidzadeh A, et al. Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin Mol Hepatol. 2014;20(3):237–48.
Cooper DS, Goldminz D, Levin AA. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983;98(1):26–9.
Azizi F, Takyar M, Madreseh E, et al. Treatment of toxic multinodular goiter: comparison of radioiodine and long-term methimazole treatment. Thyroid. 2019;29(5):625–530.
Bonnema SJ, Hegedus L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012;33:920–80.
Torring O, Tallstedt L, Wallin G, et al. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996;81:2986–93.
Nygaard B, Hegedus L, Gervil M, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves’ disease. J Intern Med. 1995;238:491–7.
Pajamäki N, Metso S, Hakala T, et al. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer. Clin Endocrinol. 2018;88(2):303–10.
Moon JH, Kim KM, Oh TJ, et al. The effect of TSH suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2017;102(1):78–85.
Kachui A, Tabatabaizadeh SM, Iraj B. Evaluation of bone density, serum total and ionized calcium, alkaline phosphatase and 25-hydroxy vitamin D in papillary thyroid carcinoma, and their relationship with TSH suppression by levothyroxine. Adv Biomed Res. 2017;6:94.
Blum MR, Bauer DC, Collet TH, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65.
Park J, Blackburn BE, Ganz PA. Risk factors for cardiovascular disease among thyroid cancer survivors: findings from the utah cancer survivors study. J Clin Endocrinol Metab. 2018;103:2468–77.
Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799–809.
Parle JV, Maisonneuve P, Sheppard MC, et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358(9285):861–5.
Bano A, Dhana K, Chaker L, et al. Association of thyroid function with life expectancy with and without cardiovascular disease. JAMA Intern Med. 2017;177(11):1650–7.
Ceresini G, Ceda GP, Lauretani F, et al. Thyroid status and 6‑year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area study. J Am Geriatr Soc. 2013;61(6):868–74.
Yeap BB, Alfonso H, Hankey GJ, et al. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health in Men study. Eur J Endocrinol. 2013;169(4):401–8.
Bano A, Chaker L, Schoufour J, et al. High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam study. J Clin Endocrinol Metab. 2018;103(1):328–35.
Khan SR, Chaker L, Ruiter R, et al. Thyroid function and cancer risk: the Rotterdam study. J Clin Endocrinol Metab. 2016;101(12):5030–6.
Aubert CE, Bauer DC, da Costa BR. The association between subclinical thyroid dysfunction and dementia: the Health, Aging and Body Composition (Health ABC) study. Clin Endocrinol (Oxf). 2017;87(5):617–26.
Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc. 2009;57(1):89–93.
Das G, Ojewuyi TA, Baglioni P, et al. Serum thyrotropin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol. 2012;77:146–51.
Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149–63.
Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240–54.
Bartalena L, Bogazzi F, Chiovato L, et al. European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7:55–66.
Lind P, Klima G, Wakonig P, et al. Urinary excretion of iodide and incidence of goiter in Styria—studies 20 years after the introduction of compulsory iodinated salt prophylaxis. Acta Med Austriaca. 1985;12:45–50.
Heinisch M, Kumnig G, Asböck D, et al. Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory iodization of common salt. Thyroid. 2002;12:809–14.
Lind P, Kumnig G, Heinisch M, et al. Iodine supplementation in Austria: methods and results. Thyroid. 2002;12(10):903–7.
Gallowitsch HJ, Mikosch P, Kresnik E, et al. Thyroid volume and iodine supply of 6 to 17 year old students. Results 3 years after the introduction of increased iodized salt. Nuklearmedizin. 1994;33:235–8.
Bundesministerium für Digitalisierung und Wirtschaftsstandort. Bundesgesetz über den Verkehr mit Speisesalz (Speisesalzgesetz) – BGBl. Nr. 112/1963 and BGBl. Nr. 288/1990. 2020. https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10010311. Zugriffen: 20.4.2020
Buchinger W. Jodversorgung in Österreich 2018. 2018. https://www.schilddruesengesellschaft.at/sites/osdg.at/files/upload/18_Buchinger_JodversorgunginOesterreich2018.pdf. Zugriffen: 20.4.2020
Lindorfer H, Krebs M, Kautzky-Willer A, et al. Iodine deficiency in pregnant women in Austria. Eur J Clin Nutr. 2015;69:349–54.
Hannan SA. The magnificent seven: a history of modern thyroid surgery. Int J Surg. 2006;4:187–91.
Verloop H, Louwerens M, Schoones JW. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97(7):2243–5558.
Kurtaran A, Schmoll-Hauer B, Tugendsam C. Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more? Wien Med Wochenschr. 2020;170(1–2):15–25.
Haymart MR, Esfandiari NH, Stang MT, et al. Controversies in the management of low-risk differentiated thyroid cancer. Endocr Rev. 2017;38(4):351–78.
Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
Silverman JF, West RL, Larkin EW, et al. The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer. 1986;57(6):1164–70.
Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260:892–9.
Tugendsam C, Petz V, Buchinger W, et al. Ultrasound criteria for risk stratification of thyroid nodules in the previously iodine deficient area of Austria—a single centre, retrospective analysis. Thyroid Res. 2018;9(11):3.
Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4):363–9.
Crockett JC. The thyroid nodule: fine-needle aspiration biopsy technique. Thrombosis J. 2017;15:14.
Knobel M. Which is the ideal treatment for benign diffuse and multinodular non-toxic goiters? Front Endocrinol (Lausanne). 2016;7:48.
Bartsch DK, Luster M, Buhr HJ. Indications for the surgical management of benign goiter in adults. Dtsch Arztebl Int. 2018;115:1–7.
Mostbeck A, Galvan G, Bauer P, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med. 1998;25(4):367–74.
Testini M, Gurrado A, Avenia N, et al. Does mediastinal extension of the goiter increase morbidity of total thyroidectomy? A multicenter study of 19,662 patients. Ann Surg Oncol. 2011;18(8):2251–9.
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.
Joseph KR, Edirimanne S, Eslick GD. Thyroidectomy for thyroid cancer in the elderly: a meta-analysis. Eur J Surg Oncol. 2019;45(3):310–7.
Duskin-Bitan H, Leibner A, Amitai O. Bone-marrow suppression in elderly patients following empiric radioiodine therapy: real-life data. Thyroid. 2019;29(5):683–91.
Chereau N, Trésallet C, Noullet S, et al. Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: a retrospective cohort analysis. Medicine. 2016;95(47):e5450.
Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135–46.
Molinaro E, Romei C, Biagini A. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644–60.
Statistik Austria. Schilddrüse. 2020. http://www.statistik.at/web_de/statistiken/menschen_und_gesellschaft/gesundheit/krebserkrankungen/schilddruese/index.html. Zugriffen: 20.4.2020
Bakiri F, Djemli FK, Mokrane LA, et al. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 1998;82(6):1146–53.